COMMISSION REGULATION (EEC) No 895/93 of 16 April 1993 amending Annexes I, II and III of  Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of  maximum residue limits of veterinary medicinal products in foodstuffs of animal origin
THE COMMISSION OF THE EUROPEAN COMMUNITIES
,
Having regard to the Treaty establishing the European Economic Community,
Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community  procedure for the establishment of maximum residue limits of veterinary medicinal products in  foodstuffs of animal origin  (1), as last amended by Commission Regulation (EEC) No 3093/92  (2)  and in particular Articles 6, 7 and 8 thereof,
Whereas, in accordance with Regulation (EEC) No 2377/90, maximum residue limits must be established  progressively for all pharmacologically active substances which are used within the Community in  veterinary medicinal products intended for administrative to food-producing animals;
Whereas maximum residue limits should be established only after the examination within the  Committee for Veterinary Medicinal Products of all the relevant information concerning the safety  of residues of the substance concerned for the consumer of foodstuffs of animal origin and the  impact of residues on the industrial processing of foodstuffs;
Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in  foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be  present, the levels which may be present in each of the relevant meat tissues obtained from the  treated animal (target tissue) and the nature of the residue which is relevant for the monitoring  of residues (marker residue);
Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum  residue limits should usually be established for the target tissues of liver or kidney; whereas,  however, the liver and kidney are frequently removed from carcasses moving in international trade,  and maximum residue limits should therefore also always be established for muscle or fat tissues;
Whereas, in the case of veterinary medicinal products intended for use in laying birds, lactating  animals or honey bees, maximum residue limits must also be established for eggs, milk or honey;
Whereas cefquinom should be inserted into Annex I to Regulation (EEC) No 2377/90;
Whereas hydrogen peroxide and sulphur should be inserted into Annex II to Regulation (EEC) No  2377/90;
Whereas thiamphenicol, triclabendazole, flubendazole and oxilbendazole should be inserted into  Annex III of Regulation (EEC) No 2377/90; whereas it is necessary to define the duration of the  provisional maximum residue limits;
Whereas a period of 60 days should be allowed before the entry into force of this Regulation in  order to allow Member States to make any adjustment which may be necessary to the authorizations to  place the veterinary medicinal products concerned on the market which have been granted in  accordance with Council Directive 81/851/EEC  (3), as amended by Directive 90/676/EEC  (4) to take  account of the provisions of this Regulation;
Whereas the measures provided for in this Regulation are in accordance with the opinion of the  Committee for the Adaptation to Technical Progress of the Directives on the Removal of Technical  Barriers to Trade in the Veterinary Medicinal Products Sector,
Annexes I, II and III of Regulation (EEC) No 2377/90 are hereby  amended as set out in the Annex hereto.
This Regulation shall enter into force on the sixtieth day following its publication in  the Official Journal of the European Communities.
This Regulation shall be binding in its entirety and directly applicable in all  Member States.